2 studies found for:    17485570 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)(COMPLETED)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Comparator: MK0431 50 mg b.i.d. (b.i.d. = twice daily);   Drug: Comparator: MK0431 100 mg q.d. (q.d. = once daily);   Drug: Comparator: Placebo (Phase A)/Metformin (Phase B);   Drug: Comparator: Metformin 500 mg b.i.d.;   Drug: Comparator: Open-Label MK0431/Metformin 50/1000 mg b.i.d.;   Drug: Comparator: Metformin 1000 mg b.i.d.
2 Completed
Has Results
The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Colesevelam HCl;   Drug: Sitagliptin

Indicates status has not been verified in more than two years